Targeting polo-like kinase 1 for cancer therapy (original) (raw)
Fenton, B. & Glover, D. M. A conserved mitotic kinase active at late anaphase–telophase in syncytial Drosophila embryos. Nature363, 637–640 (1993). ArticleCASPubMed Google Scholar
Glover, D. M., Hagan, I. M. & Tavares, A. A. Polo-like kinases: a team that plays throughout mitosis. Genes Dev.12, 3777–3787 (1998). ArticleCASPubMed Google Scholar
Clay, F. J., McEwen, S. J., Bertoncello, I., Wilks, A. F. & Dunn, A. R. Identification and cloning of a protein kinase-encoding mouse gene, Plk, related to the polo gene of Drosophila. Proc. Natl Acad. Sci. USA90, 4882–4886 (1993). ArticleCASPubMedPubMed Central Google Scholar
Lake, R. J. & Jelinek, W. R. Cell cycle- and terminal differentiation-associated regulation of the mouse mRNA encoding a conserved mitotic protein kinase. Mol. Cell. Biol.13, 7793–7801 (1993). CASPubMedPubMed Central Google Scholar
Holtrich, U. et al. Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. Proc. Natl Acad. Sci. USA91, 1736–1740 (1994). ArticleCASPubMedPubMed Central Google Scholar
Hamanaka, R. et al. Cloning and characterization of human and murine homologues of the Drosophila polo serine-threonine kinase. Cell Growth Differ.5, 249–257 (1994). CASPubMed Google Scholar
Simmons, D. L., Neel, B. G., Stevens, R., Evett, G. & Erikson, R. L. Identification of an early-growth-response gene encoding a novel putative protein kinase. Mol. Cell. Biol.12, 4164–4169 (1992). CASPubMedPubMed Central Google Scholar
Ouyang, B. et al. Human Prk is a conserved protein serine/threonine kinase involved in regulating M phase functions. J. Biol. Chem.272, 28646–28651 (1997). ArticleCASPubMed Google Scholar
Holtrich, U. et al. Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages. Oncogene19, 4832–4839 (2000). ArticleCASPubMed Google Scholar
Fode, C., Motro, B., Yousefi, S., Heffernan, M. & Dennis, J. W. Sak, a murine protein-serine/threonine kinase that is related to the Drosophila polo kinase and involved in cell proliferation. Proc. Natl Acad. Sci. USA91, 6388–6392 (1994). ArticleCASPubMedPubMed Central Google Scholar
Karn, T. et al. Human SAK related to the PLK/polo family of cell cycle kinases shows high mRNA expression in testis. Oncol. Reports4, 505–510 (1997). CAS Google Scholar
Mundt, K. E., Golsteyn, R. M., Lane, H. A. & Nigg, E. A. On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression. Biochem. Biophys. Res. Commun.239, 377–385 (1997). ArticleCASPubMed Google Scholar
Smith, M. R. et al. Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem. Biophys. Res. Commun.234, 397–405 (1997). ArticleCASPubMed Google Scholar
Eckerdt, F., Yuan, J. & Strebhardt, K. Polo-like kinases and oncogenesis. Oncogene24, 267–276 (2005). ArticleCASPubMed Google Scholar
Stevenson, C. S. et al. Scytonemin-a marine natural product inhibitor of kinases key in hyperproliferative inflammatory diseases. Inflamm. Res.51, 112–114 (2002). ArticleCASPubMed Google Scholar
Stevenson, C. S. et al. The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore. J. Pharmacol. Exp. Ther.303, 858–866 (2002). ArticleCASPubMed Google Scholar
Liu, Y. et al. Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase. Chem. Biol.12, 99–107 (2005). ArticleCASPubMed Google Scholar
Steegmaier, M. et al. BI 2536, a potent and highly selective inhibitor of Polo-like kinase 1 (Plk1), induces mitotic arrest and apoptosis in a broad spectrum of tumor cell lines. Clin. Cancer Res.11 (Suppl.), 9147 (2005). Google Scholar
Baum A et al. In vivo activity of BI 2536, a potent and selective inhibitor of the mitotic kinase Plk1, in a range of human cancer xenograft models. Clin. Cancer Res.11 (Suppl.), 9146 (2005). Google Scholar
Mross K et al. A phase I single dose escalation study of the Polo-like kinase 1 (Plk1) inhibitor BI 2536 in patients with advanced solid tumors. Clin. Cancer Res.11 (Suppl.), 9032 (2005). Google Scholar
Gumireddy, K. et al. ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. Cancer Cell7, 275–286 (2005). ArticleCASPubMed Google Scholar
Barr, F. A., Sillje, H. H. & Nigg, E. A. Polo-like kinases and the orchestration of cell division. Nature Rev. Mol. Cell Biol.5, 429–440 (2004). ArticleCAS Google Scholar
Xie, S., Xie, B., Lee, M. Y. & Dai, W. Regulation of cell cycle checkpoints by polo-like kinases. Oncogene24, 277–286 (2005). ArticlePubMedCAS Google Scholar
van Vugt, M. A. & Medema, R. H. Getting in and out of mitosis with Polo-like kinase-1. Oncogene24, 2844–2859 (2005). ArticleCASPubMed Google Scholar
Golsteyn, R. M. et al. Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. J. Cell Sci.107, 1509–1517 (1994). ArticleCASPubMed Google Scholar
Golsteyn, R. M., Mundt, K. E., Fry, A. M. & Nigg, E. A. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function. J. Cell Biol.129, 1617–1628 (1995). ArticleCASPubMed Google Scholar
Lee, K. S., Yuan, Y. L., Kuriyama, R. & Erikson, R. L. Plk is an M-phase-specific protein kinase and interacts with a kinesin-like protein, CHO1/MKLP-1. Mol. Cell. Biol.15, 7143–7151 (1995). ArticleCASPubMedPubMed Central Google Scholar
Sunkel, C. E. & Glover, D. M. polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J. Cell Sci.89, 25–38 (1988). ArticlePubMed Google Scholar
Kitada, K., Johnson, A. L., Johnston, L. H. & Sugino, A. A multicopy suppressor gene of the Saccharomyces cerevisiae G1 cell cycle mutant gene dbf4 encodes a protein kinase and is identified as CDC5. Mol. Cell. Biol.13, 4445–4457 (1993). CASPubMedPubMed Central Google Scholar
Ohkura, H., Hagan, I. M. & Glover, D. M. The conserved Schizosaccharomyces pombe kinase plo1, required to form a bipolar spindle, the actin ring, and septum, can drive septum formation in G1 and G2 cells. Genes Dev.9, 1059–1073 (1995). ArticleCASPubMed Google Scholar
Arnaud, L., Pines, J. & Nigg, E. A. GFP tagging reveals human Polo-like kinase 1 at the kinetochore/centromere region of mitotic chromosomes. Chromosoma107, 424–429 (1998). ArticleCASPubMed Google Scholar
Wianny, F., Tavares, A., Evans, M. J., Glover, D. M. & Zernicka-Goetz, M. Mouse polo-like kinase 1 associates with the acentriolar spindle poles, meiotic chromosomes and spindle midzone during oocyte maturation. Chromosoma107, 430–439 (1998). ArticleCASPubMed Google Scholar
Lee, K. S. & Erikson, R. L. Plk is a functional homolog of Saccharomyces cerevisiae Cdc5, and elevated Plk activity induces multiple septation structures. Mol. Cell. Biol.17, 3408–3417 (1997). ArticleCASPubMedPubMed Central Google Scholar
Liu, X. & Erikson, R. L. Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA. Proc. Natl Acad. Sci. USA99, 8672–8676 (2002). ArticleCASPubMedPubMed Central Google Scholar
Liu, X. & Erikson, R. L. Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc. Natl Acad. Sci. USA100, 5789–5794 (2003). ArticleCASPubMedPubMed Central Google Scholar
Jang, Y. J., Lin, C. Y., Ma, S. & Erikson, R. L. Functional studies on the role of the C-terminal domain of mammalian polo-like kinase. Proc. Natl Acad. Sci. USA99, 1984–1989 (2002). ArticleCASPubMedPubMed Central Google Scholar
Smits, V. A. et al. Polo-like kinase-1 is a target of the DNA damage checkpoint. Nature Cell Biol.2, 672–676 (2000). ArticleCASPubMed Google Scholar
van Vugt, M. A., Bras, A. & Medema, R. H. Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol. Cell15, 799–811 (2004). ArticleCASPubMed Google Scholar
van Vugt, M. A., Bras, A. & Medema, R. H. Restarting the cell cycle when the checkpoint comes to a halt. Cancer Res.65, 7037–7040 (2005). ArticleCASPubMed Google Scholar
Ando, K. et al. Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation. J. Biol. Chem.279, 25549–25561 (2004). ArticleCASPubMed Google Scholar
Hanks, S. K., Quinn, A. M. & Hunter, T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science241, 42–52 (1988). ArticleCASPubMed Google Scholar
Hanks, S. K. & Quinn, A. M. Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Methods Enzymol.200, 38–62 (1991). ArticleCASPubMed Google Scholar
Guex, N. & Peitsch, M. C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis18, 2714–2723 (1997). ArticleCASPubMed Google Scholar
Bayliss, R., Sardon, T., Vernos, I. & Conti, E. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. Mol. Cell12, 851–862 (2003). ArticleCASPubMed Google Scholar
Nowakowski, J. et al. Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography. Structure. (Camb.)10, 1659–1667 (2002). ArticleCAS Google Scholar
Cheetham, G. M. et al. Crystal structure of aurora-2, an oncogenic serine/threonine kinase. J. Biol. Chem.277, 42419–42422 (2002). ArticleCASPubMed Google Scholar
Yang, J. et al. Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nature Struct. Biol.9, 940–944 (2002). ArticleCASPubMed Google Scholar
Lowery, D. M., Lim, D. & Yaffe, M. B. Structure and function of Polo-like kinases. Oncogene24, 248–259 (2005). ArticleCASPubMed Google Scholar
Hamanaka, R. et al. Polo-like kinase is a cell cycle-regulated kinase activated during mitosis. J. Biol. Chem.270, 21086–21091 (1995). ArticleCASPubMed Google Scholar
Marshall, C. J. Signal transduction. Hot lips and phosphorylation of protein kinases. Nature367, 686 (1994). ArticleCASPubMed Google Scholar
Knighton, D. R. et al. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science253, 414–420 (1991). ArticleCASPubMed Google Scholar
Knighton, D. R. et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science253, 407–414 (1991). ArticleCASPubMed Google Scholar
Ellinger-Ziegelbauer, H. et al. Ste20-like kinase (SLK), a regulatory kinase for polo-like kinase (Plk) during the G2/M transition in somatic cells. Genes Cells5, 491–498 (2000). ArticleCASPubMed Google Scholar
Walter, S. A., Cutler, R. E. Jr, Martinez, R., Gishizky, M. & Hill, R. J. Stk10, a new member of the polo-like kinase kinase family highly expressed in hematopoietic tissue. J. Biol. Chem.278, 18221–18228 (2003). ArticleCASPubMed Google Scholar
Kelm, O., Wind, M., Lehmann, W. D. & Nigg, E. A. Cell cycle-regulated phosphorylation of the Xenopus polo-like kinase Plx1. J. Biol. Chem.277, 25247–25256 (2002). ArticleCASPubMed Google Scholar
Elia, A. E. et al. The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell115, 83–95 (2003). ArticleCASPubMed Google Scholar
Cheng, K. Y., Lowe, E. D., Sinclair, J., Nigg, E. A. & Johnson, L. N. The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex. EMBO J.22, 5757–5768 (2003). ArticleCASPubMedPubMed Central Google Scholar
Yaffe, M. B. & Cantley, L. C. Mapping specificity determinants for protein-protein association using protein fusions and random peptide libraries. Methods Enzymol.328, 157–170 (2000). ArticleCASPubMed Google Scholar
Elia, A. E., Cantley, L. C. & Yaffe, M. B. Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates. Science299, 1228–1231 (2003). ArticleCASPubMed Google Scholar
Lee, K. S., Grenfell, T. Z., Yarm, F. R. & Erikson, R. L. Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk. Proc. Natl Acad. Sci. USA95, 9301–9306 (1998). ArticleCASPubMedPubMed Central Google Scholar
Pawson, T. & Nash, P. Assembly of cell regulatory systems through protein interaction domains. Science300, 445–452 (2003). ArticleCASPubMed Google Scholar
Lin, C. Y. et al. Peripheral Golgi protein GRASP65 is a target of mitotic polo-like kinase (Plk) and Cdc2. Proc. Natl Acad. Sci. USA97, 12589–12594 (2000). ArticleCASPubMedPubMed Central Google Scholar
Preisinger, C. et al. Plk1 docking to GRASP65 phosphorylated by Cdk1 suggests a mechanism for Golgi checkpoint signalling. EMBO J.24, 753–765 (2005). ArticleCASPubMedPubMed Central Google Scholar
Lee, K. S., Song, S. & Erikson, R. L. The polo-box-dependent induction of ectopic septal structures by a mammalian polo kinase, plk, in Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA96, 14360–14365 (1999). ArticleCASPubMedPubMed Central Google Scholar
Seong, Y. S. et al. A spindle checkpoint arrest and a cytokinesis failure by the dominant-negative polo-box domain of Plk1 in U-2 OS cells. J. Biol. Chem.277, 32282–32293 (2002). ArticleCASPubMed Google Scholar
Yuan, J. et al. Polo-like kinase, a novel marker for cellular proliferation. Am. J. Pathol.150, 1165–1172 (1997). CASPubMedPubMed Central Google Scholar
Wolf, G. et al. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene14, 543–549 (1997). ArticleCASPubMed Google Scholar
Knecht, R. et al. Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Res.59, 2794–2797 (1999). CASPubMed Google Scholar
Knecht, R., Oberhauser, C. & Strebhardt, K. PLK (polo-like kinase), a new prognostic marker for oropharyngeal carcinomas. Int. J. Cancer89, 535–536 (2000). ArticleCASPubMed Google Scholar
Strebhardt, K., Kneisel, L., Linhart, C., Bernd, A. & Kaufmann, R. Prognostic value of pololike kinase expression in melanomas. JAMA283, 479–480 (2000). ArticleCASPubMed Google Scholar
Kneisel, L. et al. Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease. J. Cutan. Pathol.29, 354–358 (2002). ArticlePubMed Google Scholar
Takahashi, T. et al. Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers. Cancer Sci.94, 148–152 (2003). ArticleCASPubMed Google Scholar
Macmillan, J. C., Hudson, J. W., Bull, S., Dennis, J. W. & Swallow, C. J. Comparative expression of the mitotic regulators SAK and PLK in colorectal cancer. Ann. Surg. Oncol.8, 729–740 (2001). ArticleCASPubMed Google Scholar
Weichert, W. et al. Polo-like kinase 1 expression is a prognostic factor in human colon cancer. World J. Gastroenterol.11, 5644–5650 (2005). ArticleCASPubMedPubMed Central Google Scholar
Yamada, S. et al. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas. Oncogene23, 5901–5911 (2004). ArticleCASPubMed Google Scholar
Ahr, A. et al. Identification of high risk breast-cancer patients by gene expression profiling. Lancet359, 131–132 (2002). ArticlePubMed Google Scholar
Simizu, S. & Osada, H. Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines. Nature Cell Biol.2, 852–854 (2000). ArticleCASPubMed Google Scholar
Llamazares, S. et al. polo encodes a protein kinase homolog required for mitosis in Drosophila. Genes Dev.5, 2153–2165 (1991). ArticleCASPubMed Google Scholar
Sunkel, C. E. & Glover, D. M. polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J. Cell Sci.89, 25–38 (1988). ArticlePubMed Google Scholar
Lane, H. A. & Nigg, E. A. Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J. Cell Biol.135, 1701–1713 (1996). ArticleCASPubMed Google Scholar
Cogswell, J. P., Brown, C. E., Bisi, J. E. & Neill, S. D. Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function. Cell Growth Differ.11, 615–623 (2000). CASPubMed Google Scholar
Liu, X., Lei, M. & Erikson, R. L. Normal cells, but not cancer cells, survive severe Plk1 depletion. Mol. Cell. Biol.26, 2073–2108 (2006). Google Scholar
Spankuch-Schmitt, B. et al. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells. Oncogene21, 3162–3171 (2002). ArticleCASPubMed Google Scholar
Gray, P. J. Jr et al. Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer. Mol. Cancer Ther.3, 641–646 (2004). CASPubMed Google Scholar
Spankuch-Schmitt, B., Bereiter-Hahn, J., Kaufmann, M. & Strebhardt, K. Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. J. Natl Cancer Inst.94, 1863–1877 (2002). ArticleCASPubMed Google Scholar
Reagan-Shaw, S. & Ahmad, N. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer. FASEB J.19, 611–613 (2005). ArticleCASPubMed Google Scholar
Nogawa, M. et al. Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer. J. Clin. Invest.115, 978–985 (2005). ArticleCASPubMedPubMed Central Google Scholar
Spankuch, B. et al. Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1. J. Natl Cancer Inst.96, 862–872 (2004). ArticlePubMedCAS Google Scholar
Jackson, A. L. et al. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnol.21, 635–637 (2003). ArticleCAS Google Scholar
Daub, H., Specht, K. & Ullrich, A. Strategies to overcome resistance to targeted protein kinase inhibitors. Nature Rev. Drug Discov.3, 1001–1010 (2004). ArticleCAS Google Scholar
Shawver, L. K., Slamon, D. & Ullrich, A. Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell1, 117–123 (2002). ArticleCASPubMed Google Scholar
McInnes, C., Mezna, M. & Fischer, P. M. Progress in the discovery of polo-like kinase inhibitors. Curr. Top. Med. Chem.5, 181–197 (2005). ArticleCASPubMed Google Scholar
Jessani, N. & Cravatt, B. F. The development and application of methods for activity-based protein profiling. Curr. Opin. Chem. Biol.8, 54–59 (2004). ArticleCASPubMed Google Scholar
Walker, E. H. et al. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell6, 909–919 (2000). ArticleCASPubMed Google Scholar
Ihle, N. T. et al. Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling. Mol. Cancer Ther.3, 763–772 (2004). CASPubMed Google Scholar
Keen, N. & Taylor, S. Aurora-kinase inhibitors as anticancer agents. Nature Rev. Cancer4, 927–936 (2004). ArticleCAS Google Scholar
Wu, S. Y. et al. Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loop. Structure. (Camb.)11, 399–410 (2003). ArticleCAS Google Scholar
Ditchfield, C. et al. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J. Cell Biol.161, 267–280 (2003). ArticleCASPubMedPubMed Central Google Scholar
Hauf, S. et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol.161, 281–294 (2003). ArticleCASPubMedPubMed Central Google Scholar
Harrington, E. A. et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nature Med.10, 262–267 (2004). ArticleCASPubMed Google Scholar
Sumara, I. et al. Roles of polo-like kinase 1 in the assembly of functional mitotic spindles. Curr. Biol.14, 1712–1722 (2004). ArticleCASPubMed Google Scholar
Casenghi, M. et al. Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation. Dev. Cell5, 113–125 (2003). ArticleCASPubMed Google Scholar
Toyoshima-Morimoto, F., Taniguchi, E., Shinya, N., Iwamatsu, A. & Nishida, E. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase. Nature410, 215–220 (2001). ArticleCASPubMed Google Scholar
Yuan, J. et al. Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1. Oncogene21, 8282–8292 (2002). ArticleCASPubMed Google Scholar
Jackman, M., Lindon, C., Nigg, E. A. & Pines, J. Active cyclin B1–Cdk1 first appears on centrosomes in prophase. Nature Cell Biol.5, 143–148 (2003). ArticleCASPubMed Google Scholar
Qian, Y. W., Erikson, E., Li, C. & Maller, J. L. Activated polo-like kinase Plx1 is required at multiple points during mitosis in Xenopus laevis. Mol. Cell. Biol.18, 4262–4271 (1998). ArticleCASPubMedPubMed Central Google Scholar
Toyoshima-Morimoto, F., Taniguchi, E. & Nishida, E. Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep.3, 341–348 (2002). ArticleCASPubMedPubMed Central Google Scholar
Wasch, R. & Engelbert, D. Anaphase-promoting complex-dependent proteolysis of cell cycle regulators and genomic instability of cancer cells. Oncogene24, 1–10 (2005). ArticlePubMedCAS Google Scholar
Castro, A., Bernis, C., Vigneron, S., Labbe, J. C. & Lorca, T. The anaphase-promoting complex: a key factor in the regulation of cell cycle. Oncogene24, 314–325 (2005). ArticleCASPubMed Google Scholar
Moshe, Y., Boulaire, J., Pagano, M. & Hershko, A. Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome. Proc. Natl Acad. Sci. USA101, 7937–7942 (2004). ArticleCASPubMedPubMed Central Google Scholar
Hansen, D. V., Loktev, A. V., Ban, K. H. & Jackson, P. K. Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFβTrCP-dependent destruction of the APC inhibitor Emi1. Mol. Biol. Cell15, 5623–5634 (2004). ArticleCASPubMedPubMed Central Google Scholar
Ahonen, L. J. et al. Polo-like kinase 1 creates the tension-sensing 3F3/2 phosphoepitope and modulates the association of spindle-checkpoint proteins at kinetochores. Curr. Biol.15, 1078–1089 (2005). ArticleCASPubMed Google Scholar
Liu, X., Zhou, T., Kuriyama, R. & Erikson, R. L. Molecular interactions of Polo-like-kinase 1 with the mitotic kinesin-like protein CHO1/MKLP-1. J. Cell Sci.117, 3233–3246 (2004). ArticleCASPubMed Google Scholar
Neef, R. et al. Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis. J. Cell Biol.162, 863–875 (2003). ArticleCASPubMedPubMed Central Google Scholar
Zhou, T., Aumais, J. P., Liu, X., Yu-Lee, L. Y. & Erikson, R. L. A role for Plk1 phosphorylation of NudC in cytokinesis. Dev. Cell5, 127–138 (2003). ArticleCASPubMed Google Scholar
Yang, J. et al. Crystal structure of an activated Akt–protein kinase B ternary complex with GSK3–peptide and AMP–PNP. Nature Struct. Biol.9, 940–944 (2002). ArticleCASPubMed Google Scholar
Tokumitsu, Y. et al. Prognostic significance of polo-like kinase expression in esophageal carcinoma. Int. J. Oncol.15, 687–692 (1999). CASPubMed Google Scholar
Wolf, G. et al. Polo-like kinase: a novel marker of proliferation: correlation with estrogen-receptor expression in human breast cancer. Pathol. Res. Pract.196, 753–759 (2000). ArticleCASPubMed Google Scholar
Weichert, W. et al. Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications. Virchows Arch.446, 442–450 (2005). ArticleCASPubMed Google Scholar
Takai, N. et al. Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage. Cancer Lett.164, 41–49 (2001). ArticleCASPubMed Google Scholar
Takai, N. et al. Polo-like kinase (PLK) expression in endometrial carcinoma. Cancer Lett.169, 41–49 (2001). ArticleCASPubMed Google Scholar
Dietzmann, K., Kirches, E., von, B., Jachau, K. & Mawrin, C. Increased human polo-like kinase-1 expression in gliomas. J. Neurooncol.53, 1–11 (2001). ArticleCASPubMed Google Scholar
Ito, Y. et al. Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma. Br. J. Cancer90, 414–418 (2004). ArticleCASPubMedPubMed Central Google Scholar
Weichert, W. et al. Overexpression of Polo-like kinase 1 is a common and early event in pancreatic cancer. Pancreatology.5, 259–265 (2005). ArticleCASPubMed Google Scholar
Weichert, W. et al. Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. Prostate60, 240–245 (2004). ArticleCASPubMed Google Scholar
Mito, K. et al. Expression of Polo-like kinase (PLK1) in non-Hodgkin's lymphomas. Leuk. Lymphoma46, 225–231 (2005). ArticleCASPubMed Google Scholar
Wipf, P. & Halter, R. J. Chemistry and biology of wortmannin. Org. Biomol. Chem.3, 2053–2061 (2005). ArticleCASPubMed Google Scholar